Synjardy is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Empagliflozin; Metformin Hydrochloride.
Product ID | 0597-0180_2f7eaca8-aa25-162f-af59-8682293e8590 |
NDC | 0597-0180 |
Product Type | Human Prescription Drug |
Proprietary Name | Synjardy |
Generic Name | Empagliflozin And Metformin Hydrochloride |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2015-08-26 |
Marketing Category | NDA / NDA |
Application Number | NDA206111 |
Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
Substance Name | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
Active Ingredient Strength | 13 mg/1; mg/1 |
Pharm Classes | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],Biguanide [EPC],Biguanides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-09-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206111 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-09-12 |
Marketing Category | NDA |
Application Number | NDA206111 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-09-12 |
Marketing Category | NDA |
Application Number | NDA206111 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-09-12 |
Ingredient | Strength |
---|---|
EMPAGLIFLOZIN | 12.5 mg/1 |
SPL SET ID: | 0fdd0255-0055-65f3-b2c0-db8fbb87beae |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0597-0159 | Synjardy | empagliflozin and metformin hydrochloride |
0597-0168 | Synjardy | empagliflozin and metformin hydrochloride |
0597-0175 | Synjardy | empagliflozin and metformin hydrochloride |
0597-0180 | Synjardy | empagliflozin and metformin hydrochloride |
0597-0280 | Synjardy | empagliflozin, metformin hydrochloride |
0597-0290 | Synjardy | empagliflozin, metformin hydrochloride |
0597-0295 | Synjardy | empagliflozin, metformin hydrochloride |
0597-0300 | Synjardy | empagliflozin, metformin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SYNJARDY 79145490 4590924 Live/Registered |
Boehringer Ingelheim International GmbH 2014-02-17 |